| angiogenesis | GO:0001525 | 201 | 0.430 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.424 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.360 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.344 | |
| adaptive immune response | GO:0002250 | 155 | 0.327 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.280 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.275 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.258 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.254 | |
| endocrine system development | GO:0035270 | 98 | 0.212 | |
| placenta development | GO:0001890 | 140 | 0.200 | |
| cytokine production | GO:0001816 | 319 | 0.197 | |
| immune effector process | GO:0002252 | 321 | 0.197 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.195 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.191 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.179 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.179 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.178 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.175 | |
| regulation of cell motility | GO:2000145 | 236 | 0.169 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.166 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.160 | |
| defense response to other organism | GO:0098542 | 197 | 0.155 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.146 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.146 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.145 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.145 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.142 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.133 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.133 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.130 | |
| stem cell differentiation | GO:0048863 | 268 | 0.128 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.126 | Mouse |
| cellular amine metabolic process | GO:0044106 | 44 | 0.123 | |
| regulation of cell migration | GO:0030334 | 219 | 0.122 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.116 | |
| muscle cell development | GO:0055001 | 133 | 0.116 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.115 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.104 | |
| regulation of microvillus assembly | GO:0032534 | 3 | 0.103 | |
| amine metabolic process | GO:0009308 | 45 | 0.101 | |
| developmental maturation | GO:0021700 | 193 | 0.101 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.097 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.097 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.097 | |
| stem cell development | GO:0048864 | 219 | 0.097 | |
| chromatin organization | GO:0006325 | 206 | 0.096 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.095 | |
| regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000800 | 1 | 0.093 | |
| skeletal system development | GO:0001501 | 356 | 0.091 | |
| odontogenesis | GO:0042476 | 78 | 0.089 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.088 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.087 | |
| sensory system development | GO:0048880 | 3 | 0.086 | |
| tissue migration | GO:0090130 | 68 | 0.083 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.083 | |
| cell differentiation in spinal cord | GO:0021515 | 53 | 0.083 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.082 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.082 | |
| cell fate commitment | GO:0045165 | 210 | 0.081 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.077 | |
| tube formation | GO:0035148 | 140 | 0.077 | |
| regulation of cell activation | GO:0050865 | 289 | 0.077 | |
| defense response to bacterium | GO:0042742 | 119 | 0.076 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.075 | |
| oxidation reduction process | GO:0055114 | 342 | 0.074 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.074 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.073 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.073 | |
| cell maturation | GO:0048469 | 127 | 0.072 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.072 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.070 | |
| positive regulation of neural precursor cell proliferation | GO:2000179 | 42 | 0.070 | |
| regulation of cardioblast differentiation | GO:0051890 | 3 | 0.069 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.069 | |
| muscle tissue development | GO:0060537 | 308 | 0.068 | |
| protein secretion | GO:0009306 | 111 | 0.067 | |
| ossification | GO:0001503 | 216 | 0.067 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.066 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.064 | |
| wound healing | GO:0042060 | 157 | 0.064 | Mouse |
| leukocyte differentiation | GO:0002521 | 342 | 0.064 | |
| limbic system development | GO:0021761 | 72 | 0.064 | |
| camera type eye development | GO:0043010 | 266 | 0.063 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.063 | |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.062 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.062 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.062 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.062 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.061 | |
| humoral immune response | GO:0006959 | 57 | 0.061 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.061 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.061 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.061 | |
| cytokine secretion | GO:0050663 | 72 | 0.059 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.058 | |
| t cell differentiation | GO:0030217 | 174 | 0.056 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.056 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.056 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.055 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.054 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.052 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.052 | |
| protein ubiquitination | GO:0016567 | 171 | 0.052 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.052 | |
| response to growth factor | GO:0070848 | 198 | 0.051 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.051 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.050 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.050 | |
| pallium development | GO:0021543 | 120 | 0.050 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.050 | |
| transforming growth factor beta secretion | GO:0038044 | 1 | 0.050 | |
| stem cell maintenance | GO:0019827 | 130 | 0.049 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.049 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.049 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.048 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.048 | Mouse |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.047 | |
| cytokine biosynthetic process | GO:0042089 | 68 | 0.047 | |
| hair follicle development | GO:0001942 | 85 | 0.047 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.047 | |
| regulation of ossification | GO:0030278 | 112 | 0.047 | |
| regulation of endothelial cell migration | GO:0010594 | 22 | 0.046 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.046 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.046 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.046 | |
| stem cell proliferation | GO:0072089 | 117 | 0.046 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.045 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.045 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.045 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.045 | |
| forebrain development | GO:0030900 | 302 | 0.044 | |
| epithelium migration | GO:0090132 | 63 | 0.044 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.044 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.044 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.044 | |
| regulation of protein localization | GO:0032880 | 231 | 0.044 | |
| histone modification | GO:0016570 | 159 | 0.044 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.043 | |
| embryonic placenta development | GO:0001892 | 98 | 0.043 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.043 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.043 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.042 | |
| interferon gamma production | GO:0032609 | 67 | 0.042 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.042 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.042 | |
| regulation of purine nucleotide biosynthetic process | GO:1900371 | 34 | 0.041 | |
| heart morphogenesis | GO:0003007 | 178 | 0.041 | |
| jak stat cascade | GO:0007259 | 42 | 0.041 | |
| phenol containing compound biosynthetic process | GO:0046189 | 21 | 0.041 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.040 | |
| chromatin modification | GO:0016568 | 187 | 0.040 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.040 | |
| neuromuscular process | GO:0050905 | 99 | 0.040 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.039 | |
| spinal cord development | GO:0021510 | 81 | 0.039 | |
| regulation of system process | GO:0044057 | 200 | 0.039 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.038 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.038 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.038 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.038 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.038 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.038 | |
| regulation of neuroblast proliferation | GO:1902692 | 27 | 0.038 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.038 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.037 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.037 | |
| blastocyst development | GO:0001824 | 80 | 0.037 | |
| regulation of neuron death | GO:1901214 | 134 | 0.037 | |
| forebrain neuron fate commitment | GO:0021877 | 13 | 0.037 | |
| telencephalon development | GO:0021537 | 186 | 0.036 | |
| nephron development | GO:0072006 | 109 | 0.036 | |
| t cell activation | GO:0042110 | 289 | 0.036 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.036 | |
| artery development | GO:0060840 | 53 | 0.036 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.036 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.035 | |
| protein methylation | GO:0006479 | 81 | 0.035 | |
| cartilage development | GO:0051216 | 140 | 0.035 | |
| response to inorganic substance | GO:0010035 | 96 | 0.035 | |
| midgut development | GO:0007494 | 4 | 0.035 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.035 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.035 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.034 | |
| cerebral cortex development | GO:0021987 | 86 | 0.034 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.034 | |
| nephron epithelium development | GO:0072009 | 92 | 0.034 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.034 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.034 | |
| epithelial tube formation | GO:0072175 | 130 | 0.034 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.034 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.034 | |
| ventral spinal cord development | GO:0021517 | 48 | 0.033 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.033 | |
| endothelial cell migration | GO:0043542 | 44 | 0.033 | |
| male sex differentiation | GO:0046661 | 109 | 0.033 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.033 | |
| axonogenesis | GO:0007409 | 274 | 0.033 | |
| gliogenesis | GO:0042063 | 141 | 0.033 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.033 | |
| transdifferentiation | GO:0060290 | 1 | 0.033 | |
| cellular homeostasis | GO:0019725 | 240 | 0.033 | |
| neuron migration | GO:0001764 | 122 | 0.033 | |
| chemotaxis | GO:0006935 | 247 | 0.032 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.032 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.032 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.032 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.032 | |
| negative regulation of growth | GO:0045926 | 99 | 0.032 | |
| regulation of gliogenesis | GO:0014013 | 50 | 0.032 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.031 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.031 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.031 | |
| neural tube development | GO:0021915 | 160 | 0.031 | |
| brain segmentation | GO:0035284 | 3 | 0.031 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.031 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.031 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.031 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.031 | |
| spemann organizer formation | GO:0060061 | 2 | 0.031 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.030 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.030 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.030 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.030 | |
| regionalization | GO:0003002 | 337 | 0.030 | |
| neuron fate specification | GO:0048665 | 30 | 0.030 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.030 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.030 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.030 | |
| hypothalamus development | GO:0021854 | 16 | 0.030 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.030 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.029 | |
| somitogenesis | GO:0001756 | 69 | 0.029 | |
| positive regulation of transforming growth factor beta secretion | GO:2001203 | 1 | 0.029 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.029 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.029 | |
| cardiac septum development | GO:0003279 | 59 | 0.029 | |
| epithelial cell development | GO:0002064 | 159 | 0.029 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.028 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.028 | |
| positive regulation of auditory receptor cell differentiation | GO:0045609 | 1 | 0.028 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.028 | |
| pancreatic a cell fate commitment | GO:0003326 | 2 | 0.028 | |
| male gonad development | GO:0008584 | 88 | 0.028 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.028 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.028 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.028 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.027 | |
| protein alkylation | GO:0008213 | 81 | 0.027 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.027 | |
| extracellular structure organization | GO:0043062 | 148 | 0.027 | |
| myeloid leukocyte mediated immunity | GO:0002444 | 42 | 0.027 | |
| forebrain morphogenesis | GO:0048853 | 17 | 0.027 | |
| segmentation | GO:0035282 | 93 | 0.027 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.027 | |
| circulatory system process | GO:0003013 | 197 | 0.026 | |
| axon guidance | GO:0007411 | 141 | 0.026 | |
| sensory perception | GO:0007600 | 245 | 0.026 | |
| cellular response to lipid | GO:0071396 | 145 | 0.026 | |
| renal sodium excretion | GO:0035812 | 3 | 0.026 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.026 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.026 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.026 | |
| neuromuscular process controlling posture | GO:0050884 | 14 | 0.025 | |
| cerebellar cortex development | GO:0021695 | 48 | 0.025 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.025 | |
| epithelial cell migration | GO:0010631 | 63 | 0.025 | |
| positive regulation of neuroblast proliferation | GO:0002052 | 19 | 0.025 | |
| cd4 positive alpha beta t cell differentiation | GO:0043367 | 41 | 0.025 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.025 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.025 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.024 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.024 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.024 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.024 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.024 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.024 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.024 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.024 | |
| cardiac chamber development | GO:0003205 | 108 | 0.024 | |
| cd4 positive alpha beta t cell activation | GO:0035710 | 45 | 0.024 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.024 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.024 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.024 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.024 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.024 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.024 | |
| regulation of secretion | GO:0051046 | 274 | 0.024 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.024 | |
| response to acid chemical | GO:0001101 | 111 | 0.024 | |
| sperm motility | GO:0030317 | 47 | 0.023 | Mouse |
| neuron death | GO:0070997 | 154 | 0.023 | |
| fat cell differentiation | GO:0045444 | 160 | 0.023 | |
| methylation | GO:0032259 | 134 | 0.023 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.023 | |
| macromolecule methylation | GO:0043414 | 120 | 0.023 | |
| fertilization | GO:0009566 | 127 | 0.023 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.023 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.023 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.023 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.023 | |
| metanephros development | GO:0001656 | 79 | 0.023 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.023 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.023 | |
| hindbrain development | GO:0030902 | 128 | 0.023 | |
| spinal cord patterning | GO:0021511 | 25 | 0.023 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.023 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.022 | |
| bone development | GO:0060348 | 120 | 0.022 | |
| b cell activation | GO:0042113 | 161 | 0.022 | |
| glial cell differentiation | GO:0010001 | 131 | 0.022 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.022 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.022 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.022 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.022 | |
| protein catabolic process | GO:0030163 | 221 | 0.022 | |
| negative regulation of adaptive immune response | GO:0002820 | 25 | 0.022 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.022 | |
| face morphogenesis | GO:0060325 | 29 | 0.022 | |
| pituitary gland development | GO:0021983 | 38 | 0.022 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.021 | |
| ear morphogenesis | GO:0042471 | 118 | 0.021 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.021 | |
| cell fate determination | GO:0001709 | 32 | 0.021 | |
| sclerotome development | GO:0061056 | 4 | 0.021 | |
| skin development | GO:0043588 | 220 | 0.021 | |
| neuroepithelial cell differentiation | GO:0060563 | 37 | 0.021 | |
| t cell proliferation | GO:0042098 | 120 | 0.021 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.021 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.021 | |
| regulation of epithelial cell migration | GO:0010632 | 35 | 0.021 | |
| positive regulation of inner ear receptor cell differentiation | GO:2000982 | 1 | 0.021 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.021 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.021 | |
| diencephalon development | GO:0021536 | 63 | 0.021 | |
| response to radiation | GO:0009314 | 165 | 0.021 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.020 | |
| blastocyst formation | GO:0001825 | 33 | 0.020 | |
| blood circulation | GO:0008015 | 195 | 0.020 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.020 | |
| response to parathyroid hormone | GO:0071107 | 3 | 0.020 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.020 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.020 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.020 | |
| gland development | GO:0048732 | 330 | 0.020 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.020 | |
| innate immune response | GO:0045087 | 157 | 0.020 | |
| monovalent inorganic cation homeostasis | GO:0055067 | 33 | 0.020 | |
| cognition | GO:0050890 | 149 | 0.020 | |
| protein processing | GO:0016485 | 163 | 0.020 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.020 | Mouse |
| regulation of fibroblast growth factor production | GO:0090270 | 4 | 0.019 | |
| negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002823 | 23 | 0.019 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.019 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.019 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.019 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.019 | |
| forebrain regionalization | GO:0021871 | 25 | 0.019 | |
| auditory receptor cell fate specification | GO:0042667 | 1 | 0.019 | |
| myotube differentiation | GO:0014902 | 105 | 0.019 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.019 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.019 | |
| regulation of interleukin 12 production | GO:0032655 | 30 | 0.019 | |
| lens morphogenesis in camera type eye | GO:0002089 | 24 | 0.019 | |
| metanephric tubule development | GO:0072170 | 18 | 0.019 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.019 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.019 | |
| cell growth | GO:0016049 | 130 | 0.019 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.019 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.019 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.019 | |
| regulation of nucleotide biosynthetic process | GO:0030808 | 34 | 0.019 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.019 | |
| metanephric dct cell differentiation | GO:0072240 | 3 | 0.019 | |
| tumor necrosis factor superfamily cytokine production | GO:0071706 | 51 | 0.019 | |
| forebrain cell migration | GO:0021885 | 58 | 0.019 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.019 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.019 | |
| cytokine metabolic process | GO:0042107 | 71 | 0.019 | |
| response to oxidative stress | GO:0006979 | 123 | 0.018 | |
| neural tube formation | GO:0001841 | 108 | 0.018 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.018 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.018 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.018 | |
| polarity specification of proximal distal axis | GO:0010085 | 2 | 0.018 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.018 | |
| response to metal ion | GO:0010038 | 47 | 0.018 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.018 | |
| calcium ion transport | GO:0006816 | 159 | 0.018 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.018 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.018 | |
| regulation of isoprenoid metabolic process | GO:0019747 | 1 | 0.018 | |
| regulation of interferon gamma production | GO:0032649 | 57 | 0.018 | |
| embryonic heart tube formation | GO:0003144 | 1 | 0.018 | |
| hippocampus development | GO:0021766 | 52 | 0.018 | |
| regulation of histone modification | GO:0031056 | 56 | 0.018 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.018 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.018 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.018 | |
| axial mesoderm formation | GO:0048320 | 3 | 0.018 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.018 | |
| regulation of binding | GO:0051098 | 111 | 0.018 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.018 | |
| spinal cord oligodendrocyte cell fate specification | GO:0021530 | 3 | 0.018 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.018 | |
| endoderm development | GO:0007492 | 45 | 0.017 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.017 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.017 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.017 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.017 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.017 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.017 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.017 | |
| kidney epithelium development | GO:0072073 | 121 | 0.017 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.017 | |
| regulation of defense response | GO:0031347 | 233 | 0.017 | |
| fat soluble vitamin metabolic process | GO:0006775 | 11 | 0.017 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.017 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.017 | |
| germ cell development | GO:0007281 | 185 | 0.017 | |
| head morphogenesis | GO:0060323 | 34 | 0.017 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.017 | Mouse |
| biomineral tissue development | GO:0031214 | 64 | 0.017 | |
| renal tubule development | GO:0061326 | 87 | 0.017 | |
| regulation of ion transport | GO:0043269 | 215 | 0.016 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.016 | |
| metanephric thick ascending limb development | GO:0072233 | 2 | 0.016 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.016 | |
| positive regulation of transcription via serum response element binding | GO:0010735 | 1 | 0.016 | |
| positive regulation of transforming growth factor beta2 production | GO:0032915 | 2 | 0.016 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.016 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.016 | |
| cell fate determination involved in pattern specification | GO:0060582 | 1 | 0.016 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.016 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.016 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.016 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.016 | |
| negative regulation of leukocyte mediated immunity | GO:0002704 | 29 | 0.016 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.016 | |
| interleukin 12 production | GO:0032615 | 32 | 0.016 | |
| metanephric ascending thin limb development | GO:0072218 | 2 | 0.016 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.016 | |
| mesonephros development | GO:0001823 | 97 | 0.016 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.016 | |
| cell fate specification | GO:0001708 | 72 | 0.016 | |
| organelle localization | GO:0051640 | 179 | 0.016 | |
| determination of heart left right asymmetry | GO:0061371 | 48 | 0.016 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.016 | |
| renal vesicle induction | GO:0072034 | 3 | 0.016 | |
| striated muscle cell development | GO:0055002 | 125 | 0.015 | |
| mitral valve development | GO:0003174 | 4 | 0.015 | |
| non canonical wnt signaling pathway via mapk cascade | GO:0038030 | 3 | 0.015 | |
| molting cycle | GO:0042303 | 90 | 0.015 | |
| brain morphogenesis | GO:0048854 | 32 | 0.015 | |
| negative regulation of cell fate specification | GO:0009996 | 4 | 0.015 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.015 | |
| regulation of oligodendrocyte differentiation | GO:0048713 | 23 | 0.015 | |
| embryonic heart tube development | GO:0035050 | 65 | 0.015 | |
| positive regulation of epidermis development | GO:0045684 | 13 | 0.015 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.015 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.015 | |
| fat cell proliferation | GO:0070341 | 4 | 0.015 | Mouse |
| regulation of kidney development | GO:0090183 | 40 | 0.015 | |
| cochlea morphogenesis | GO:0090103 | 22 | 0.015 | |
| regeneration | GO:0031099 | 38 | 0.015 | |
| urogenital system development | GO:0001655 | 261 | 0.015 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.015 | |
| neuron projection guidance | GO:0097485 | 141 | 0.015 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.015 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.015 | |
| metanephric nephron epithelium development | GO:0072243 | 19 | 0.015 | |
| regulation of protein processing | GO:0070613 | 96 | 0.015 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.015 | |
| establishment of endothelial blood brain barrier | GO:0014045 | 3 | 0.015 | |
| protein maturation | GO:0051604 | 176 | 0.015 | |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.015 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.015 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.015 | |
| cell recognition | GO:0008037 | 83 | 0.015 | |
| vitamin metabolic process | GO:0006766 | 23 | 0.015 | |
| cellular response to parathyroid hormone stimulus | GO:0071374 | 2 | 0.015 | |
| inflammatory response | GO:0006954 | 244 | 0.015 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.015 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.015 | |
| positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000802 | 1 | 0.015 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.015 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.015 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.015 | |
| regulation of production of molecular mediator of immune response | GO:0002700 | 65 | 0.015 | |
| negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | GO:0072040 | 4 | 0.014 | |
| action potential | GO:0001508 | 78 | 0.014 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.014 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.014 | |
| bone morphogenesis | GO:0060349 | 78 | 0.014 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.014 | |
| exocytosis | GO:0006887 | 121 | 0.014 | |
